Balyasny Asset Management »

Aldeyra Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $66k 19k 3.51
2023-09-30 $451k 68k 6.68
2023-06-30 $125k 15k 8.39
2023-03-31 $263k 27k 9.93
2022-12-31 $217k 31k 6.96
2021-03-31 $142k 12k 11.87

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Financial (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Hess Put Option (HES)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
JPMorgan Chase & Co. Call Option (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Union Pacific Corporation Call Option (UNP)
Select Sector Spdr Tr Technology (XLK)
Boeing Company (BA)
Deere & Company (DE)

View all positions for Balyasny Asset Management

Top funds holding Aldeyra Therapeutics

Perceptive Advisors
Knoll Capital Management
Vanguard Group
Kennedy Capital Management
Dimensional Fund Advisors
Damian Sousa
Millennium Management
Thomas Stevens, CFA"
Bank of America Corporation
Two Sigma Advisers
Wells Fargo & Company
Deutsche Bank Aktiengesellschaft
D. E. Shaw & Co
Palo Alto Investors
Two Sigma Investments

View all funds holding Aldeyra Therapeutics